ANI Pharmaceuticals reported $54.08M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
AbbVie USD 4.4B 2.52B Mar/2025
ANI Pharmaceuticals USD 54.08M 5.72M Jun/2025
Aurora Cannabis CAD -11427000 13.94M Jun/2025
Canopy Growth CAD -21827000 13.2M Jun/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Knight Therapeutics CAD 16.72M 1.05M Sep/2024
Novartis USD 6.08B 739M Jun/2025
Perrigo USD 129.1M 1.9M Jun/2025
Sun Pharmaceuticals INR 39.48B 5.23B Jun/2025
Teva Pharmaceutical Industries USD 1.23B 124M Jun/2025